Multiple Myeloma Medications

2mg

Formulated to address malignant cell proliferation by supporting the alkylation of DNA and inhibiting cellular replication.

50mg

Utilized to target malignant neoplasms to alleviate disease progression and cell proliferation.

10mg

Indicated to address haematological malignancies to support cancer remission.

50 · 100mg

formulated to alleviate symptoms of multiple myeloma to support patient stabilization.